BSE filing, NSE: RAMCOSYS. Summary written from the filing by ALFA Finder's alert engine.
Ramco Systems Ltd: key numbers
- Share price
- ₹522.20
- Market cap
- ₹1,966 Cr
- Revenue (annual)
- ₹705.1 Cr
- Net profit (annual)
- ₹41.84 Cr
- P/E (TTM)
- 67.4×Sector 23.0×
- Promoter holding
- 55.44%-0.07% QoQ
- FII holding
- 10.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ramco Systems Ltd
All →Ramco Systems Results Update
Ramco Systems released its Q2 FY27 press release, showing USD 19.20m revenue, USD 2.87m EBITDA and a fact sheet. The filing also includes a consolidated income statement in USD.
Ramco Systems Q2 FY27 Results: Net Profit ₹0.4 Cr, Down 96.8% YoY
Ramco Systems Ltd reported revenue from operations of ₹182 Cr (+3.5% YoY) and net profit of ₹0.4 Cr (-96.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.4 Cr · -96.8% YoY
Ramco Systems Credit Rating
ICRA upgraded the credit rating for Ramco Systems Limited's ₹150.00 Crore bank facilities. This regulatory disclosure provides details of the revised ratings for existing credit lines.
- Value
- ₹150.0 Cr
Ramco Systems Other Announcement
Ramco Systems Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory disclosure under SEBI LODR.
Ramco Systems Board Meeting Date
Ramco Systems will hold a board meeting on October 23, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Ramco Systems Business Update
Ramco Systems received Frost & Sullivan's 2026 Global Technology Innovation Leadership Recognition for its aviation software. No new contract, order or financial figure is announced.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date